3Kaschek O. Endoscopic surgert of chronic sinusitis, the importance ofpostoperative treatment [J ]. Therapie-Woche, 1994, 44(7) : 408.
4Meister R, Witting T, Beuscher N, et al. Efficacy and tocerability of rnyrtol standardized in long term treatment of chronic bronchitis[J]. Drug Research, 1999, (4): 351.
二级参考文献14
1Straehler-Pohl HJ, Burmeister G. Use of Gelomyrtol forte in sinusitides A course study[J]. ZFA (Stuttgart). 1978, Apr 54:611-615.
2Federspil P, Wulkow R, Zimmermann T. Effects of standardized Myrtol in therapy of acute sinusitis-results of a double-blind,randomized multicenter study compared with placebo[J]. Laryngorhinootologie. 1997, 76:23-27.
3Matthys H, De Mey C, Carls C, et al. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. Cefuroxime and ambroxol[ J ]. Arzneimittelforschung,2000, 50:700-711.
4Meister R, Witting T, Beuscher N, et al. Efficacy and Tolerability of Myrtol Standardized in Long-term Treatment of Chronic Bronchitis. A double-blind, placebo-controlled study. Study Group Investigators[J]. Arzneimttelforsc-hung, 1999, 49:351-358.
5Ulmer WT, Scha D. Chronic obstructive bronchitis. Effect of Gelomrtol forte in a placebo-controlled double-blind study[J ].Fortschr Med. 1991, 109:547-550.
6Sengespeik HC, Zimmermann T, Peiske C, et al. Myrtol Standardized in the Treatment of Acute and Chronic Respiratory Infections in Children/A multicenter postmarketing surveillance study[J]. Arzneimittelforsc-hung, 1998, 48:990-994.
7Dorow P, Weiss Th, Felix R, et al. Effect of a Secretolytic and a Combination of Pinene, Limonene and Cineole on Mucociliary Clearance in Patients with Chronic Pulmonary Obstruction[J].Arzneim Forsch, 1987, 37:1378-1381.
8Zimmermann Th, Seiberling M, Thomann P, et al. Evaluation of the Relative Bioavailability and the Pharmacokinetics of Myrtol Standardized[J]. Arzneim Forsch, 1995, 45 : 1198-1201.
9Uehleke H, Brinkschulte-Freitas M. Oral toxicity of an essential oil from myrtle and adaptive liver stimulation[ J ]. Toxicology,(1979) 12(3) :335-342.
10Gall H, Kaehler A, Peter RU. Anaphylactic shock reaction to dibutyl-phthalate-containing capsules[J]. Dermatology, 1999,199:169-170.
6Pauwels RA, Buist AS, Calverley PM, et at. Global strategy for the diagno- sis, management, and prevention of chronic obstructive pulmonary dis- ease, NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary[J]. Am J Respir Crit Care Med, 2001:163 (5): 1 256- 1 276.
7Pauwels RA, Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD) [J]. Lancet,2004,364(9 434): 613 - 620.
